Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v3-EN
Language French English
Date Updated 2021-04-07 2021-04-07
Drug Identification Number 02407590 02407590
Brand name APO-TETRABENAZINE APO-TETRABENAZINE
Common or Proper name TETRABENAZINE TETRABENAZINE
Company Name APOTEX INC APOTEX INC
Ingredients TETRABENAZINE TETRABENAZINE
Strength(s) 25MG 25MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 BTL 100 BTL
ATC code N07XX N07XX
ATC description OTHER NERVOUS SYSTEM DRUGS OTHER NERVOUS SYSTEM DRUGS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-03-29 2021-03-29
Estimated end date 2021-04-23 2021-04-23
Actual end date
Shortage status Actual shortage Actual shortage
Company comments
Health Canada comments